4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-21-006095
Options or other derivatives
- Chief Financial Officer acquired 60,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Branning Todd P. Chief Financial Officer | 2021-01-28 | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | D | ||
Loading xslF345X03/doc4.xml…